Alnylam Pharmaceuticals ROA - Return on Assets 2010-2024 | ALNY

Alnylam Pharmaceuticals return on assets for the quarter ending September 30, 2024 was -8.39.

  • Alnylam Pharmaceuticals average return on assets for 2023 was -22, a 26.79% decline from 2022.
  • Alnylam Pharmaceuticals average return on assets for 2022 was -30.05, a 18.12% decline from 2021.
  • Alnylam Pharmaceuticals average return on assets for 2021 was -25.44, a 19.7% increase from 2020.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.

Alnylam Pharmaceuticals ROA - Return on Assets 2010-2024 | ALNY

  • Alnylam Pharmaceuticals average return on assets for 2023 was -22, a 26.79% decline from 2022.
  • Alnylam Pharmaceuticals average return on assets for 2022 was -30.05, a 18.12% decline from 2021.
  • Alnylam Pharmaceuticals average return on assets for 2021 was -25.44, a 19.7% increase from 2020.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.